Thursday, May 17, 2012
March 12, 2012. Third time's the charm! Bydureon has been approved, and was made available for sale in pharmacies on February 13, 2012. The Obesity-news.com drug approval package is now on-line for subscribers. (link) This package is also available in PDF form for $49. If you are interested, please write us for further details.
If you are a current subscriber, you may access the file above using your user name and password. Non-subscribers may gain access by subscribing on-line.
The next drug update on Qnexa will go on-line next week. In addition, the archives of Obesity Update will be taken off line. This service was discontinued in 2007 and replaced with our current drug database. In its place you will find FREE news on new drug targets, preclinical drug research and other relevant diabetes and obesity news. Stories will remain on-line for 30 days.
Last update to drug database February 25, 2012 (link).
header
Obesity-news is a publication of Hirsch Communications. An on-line subscription is $104.00 per month, payable in advance by American Express, VISA or Mastercard. Subscribing is simple using our secure on-line subscription form. A yearly subscription is also available for $999 per year through EBSCO or Swets Blackwell subscription services. Please contact them for more information. Obesity-news also accepts fax orders at 703/960-7462. Copyright 1997-2012, all rights reserved.
IMPORTANT: All information in this publication is believed to be accurate and true. Publisher is not liable for omissions or inaccuracies. Information in this newsletter is for educational purposes only and should not be construed as medical advice, or be used in lieu of consultation with a health care provider.
|